Gartner, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Gartner, Inc. (IT) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$219.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-04
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$52.07M, a 138.57% decline year-over-year.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $135.01M.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$55.51M, a 127.61% decline year-over-year.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $201.00M.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$264.50M, a 139.42% decline from fiscal 2024.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $671.04M, a 8.06% increase from fiscal 2023.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $621.01M.
- Gartner, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$43.58M, a 158.58% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$219.69M 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | -$52.07M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$264.50M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | -$562.96M 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $215.57M 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | $135.01M 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | $671.04M 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $454.21M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | -$48.46M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | -$55.51M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $621.01M 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $574.50M 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | $481.09M 10-Q · filed 2024-07-30 | |||
| 2023-03-31 | $201.00M 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | -$43.58M 10-K · filed 2025-02-13 | |||
| 2022-09-30 | -$189.69M 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | -$375.54M 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | -$294.96M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $74.39M 10-K · filed 2024-02-15 | |||
| 2021-09-30 | $71.80M 10-Q · filed 2022-11-01 | |||
| 2021-06-30 | $95.16M 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | -$258.44M 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $403.17M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $263.96M 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $77.30M 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | -$37.28M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $118.56M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $151.79M 10-Q · filed 2020-11-03 | |||
| 2019-06-30 | $59.18M 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | -$10.20M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$401.91M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | -$347.32M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | -$404.09M 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | -$343.04M 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $41.80M 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $120.44M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $122.81M 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $765.80M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $92.89M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |